Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease

Background and Purpose— The aim of this study was to explore the possible contribution of alterations in cerebral hemodynamics to the evolution of cognitive impairment in patients with Alzheimer disease (AD). Method— Fifty-three patients with AD were investigated. The evolution of cognitive decline over 12 months was evaluated by means of changes in Mini Mental State Examination (MMSE) and AD Assessment Scale for Cognition (ADAS-Cog) scores. Demographic characteristics, vascular risk profile, pharmacological treatment, and presence of white matter lesions were assessed at entry. Further, a basal evaluation of cerebrovascular reactivity to hypercapnia was measured with transcranial Doppler ultrasonography using the breath-holding index (BHI). Results— Of all the variables considered, both MMSE and ADAS-Cog changes had the highest correlation with BHI, followed by age and diabetes. After subdividing both cognitive measures reductions into bigger and smaller-than-average decline (2 points for MMSE; 5 points for ADAS-Cog), multiple logistic regression indicated BHI as the sole significant predictor of cognitive decline. Conclusions— These results show an association between impaired cerebral microvessels functionality and unfavorable evolution of cognitive function in patients with AD. Further research is needed to fully establish whether altered cerebral hemodynamics may be considered an independent factor in sustaining cognitive decline progression or an effect of pathological processes involved in AD.

[1]  K. Langa,et al.  Mixed dementia: emerging concepts and therapeutic implications. , 2004, JAMA.

[2]  Costantino Iadecola,et al.  Vascular Cognitive Impairment: Introduction , 2004 .

[3]  P. Gorelick,et al.  Risk Factors for Vascular Dementia and Alzheimer Disease , 2004, Stroke.

[4]  M. Walters,et al.  Effect of Perindopril on Cerebral Vasomotor Reactivity in Patients With Lacunar Infarction , 2004, Stroke.

[5]  O. Hanon,et al.  Prevention of dementia and cerebroprotection with antihypertensive drugs , 2004, Current hypertension reports.

[6]  K. Jellinger.  Vascular Cognitive Impairment: Preventable Dementia , 2004 .

[7]  B. Kemp,et al.  Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. , 2004, American journal of physiology. Heart and circulatory physiology.

[8]  J. Schneider,et al.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology , 2004, Neurology.

[9]  Thomas G. Beach,et al.  Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[10]  T. Beach,et al.  Cortical and Leptomeningeal Cerebrovascular Amyloid and White Matter Pathology in Alzheimer’s Disease , 2003, Molecular medicine.

[11]  J. Bowler.  Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease. , 2003, Stroke.

[12]  C. Iadecola,et al.  Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia , 2003, Stroke.

[13]  B. Reisberg,et al.  Vascular cognitive impairment , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  D. Royall,et al.  Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.

[15]  J. C. Torre,et al.  Alzheimer Disease as a Vascular Disorder: Nosological Evidence , 2002 .

[16]  R. Kalaria.  Small Vessel Disease and Alzheimer’s Dementia: Pathological Considerations , 2002, Cerebrovascular Diseases.

[17]  E. Barrett-Connor,et al.  Serum lipoprotein levels, statin use, and cognitive function in older women. , 2002, Archives of neurology.

[18]  D. Altman,et al.  Analysing controlled trials with baseline and follow up measurements , 2001, BMJ : British Medical Journal.

[19]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[20]  F Placidi,et al.  Cerebrovascular reactivity and subcortical infarctions. , 2001, Archives of neurology.

[21]  L. Provinciali,et al.  Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy. , 2001, Journal of applied physiology.

[22]  C. DeCarli,et al.  Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy , 2000, Neurology.

[23]  C Caltagirone,et al.  Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. , 2000, JAMA.

[24]  B. Lebowitz,et al.  Norms for the Mini-Mental State Examination in a healthy population , 1999, Neurology.

[25]  C. Harley,et al.  Contents Vol. 53, 1999 , 1999, Brain, Behavior and Evolution.

[26]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[27]  D. Mant.  Prevention , 1994, The Lancet.

[28]  F. Fabris,et al.  The Italian version of the Alzheimer's Disease Assessment Scale (ADAS): psychometric and normative characteristics from a normal aged population. , 1994, Archives of gerontology and geriatrics.

[29]  C. Grady,et al.  Reduction of Functional Neuronal Connectivity in Long‐term Treated Hypertension , 1994, Stroke.

[30]  M. Matsumoto,et al.  Reactivity of Cerebral Blood Flow to Carbon Dioxide in Various Types of Ischemic Cerebrovascular Disease: Evaluation by the Transcranial Doppler Method , 1993, Stroke.

[31]  H. Markus,et al.  Estimation of Cerebrovascular Reactivity Using Transcranial Doppler, Including the Use of Breath‐Holding as the Vasodilatory Stimulus , 1992, Stroke.

[32]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.